Table 6.
Fine-needle aspiration assay | Malignant | Benign | Total |
---|---|---|---|
BETHESDA 5,6 | 12 (86%) | 2 (14.28%) | 14 (4%) |
BETHESDA 2 | 3 (14.28%) | 18 (86%) | 21 (6%) |
Total | 15 (43%) | 20 (57.14%) | 35 (100%) |
Fine-needle aspiration assay | Malignant | Benign | Total |
---|---|---|---|
BETHESDA 5,6 | 12 (86%) | 2 (14.28%) | 14 (4%) |
BETHESDA 2 | 3 (14.28%) | 18 (86%) | 21 (6%) |
Total | 15 (43%) | 20 (57.14%) | 35 (100%) |